OOIR: Observatory of International Research

Papers

(The H4-Index of Nanomedicine-Nanotechnology Biology and Medicine is 23. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2021-11-01 to 2025-11-01.)

Article	Citations
Robust aptamer-targeted CRISPR/Cas9 delivery using mesenchymal stem cell membrane –liposome hybrid: BIRC5 gene knockout against melanoma	68
Corrigendum to “A light-up “G-quadruplex nanostring” for label-free and selective detection of miRNA via duplex-specific nuclease mediated tandem rolling circle amplification” [Nanomed.: Nanotechnol.	65
A novel bidirectional perfusion-like administered system for NIR-II fluorescence imaging precision diagnosis of bladder cancer	59
Macrophage membrane modified baicalin liposomes improve brain targeting for alleviating cerebral ischemia reperfusion injury	54
Engineered photonic near-infrared light activated photothermal theranostic nanovaccine induced targeted remodeling of tumor microenvironment	50
Comparative examination of the chemistry and biology of AI-driven gold NPs in Theranostics: New insights into biosensing, bioimaging, genomics, diagnostics, and therapy	50
Delivery of gene editing therapeutics	43
Dye labeling for optical imaging biases drug carriers' biodistribution and tumor uptake	40
Diethyldithiocarbamate copper nanoparticle overcomes resistance in cancer therapy without inhibiting P-glycoprotein	37
Therapeutic effects of cationic liposomes on lupus-prone MRL/lpr mice are mediated via inhibition of TLR4-triggered B-cell activation	35
Novel combination of bioactive agents in bilayered dermal patches provides superior wound healing	34
Peroxidase modification-driven silymarin liposomes for the treatment of liver fibrosis	34
Determination of spectroscopy marker of atherosclerotic carotid stenosis using FTIR-ATR combined with machine learning and chemometrics analyses	32
In vitro assessment of nanomedicines' propensity to cause palmar-plantar erythrodysesthesia: A Doxil vs. doxorubicin case study	30
Coatsome-replicon vehicles: Self-replicating RNA vaccines against infectious diseases	29
Chitosan-covered calcium phosphate particles as a drug vehicle for delivery to the eye	27
Cyclo(RGD) peptide-decorated silver nanoparticles with anti-platelet potential for active platelet-rich thrombus targeting	25
Electrospun electroconductive constructs of aligned fibers for cardiac tissue engineering	25
Targeting prostate cancer with Clostridium perfringens enterotoxin functionalized nanoparticles co-encapsulating imaging cargo enhances magnetic resonance imaging specificity	24
Exploiting the preferential phagocytic uptake of nanoparticle-antigen conjugates for the effective treatment of autoimmunity	24
Poly(lipoic acid)-based nanoparticles as a new therapeutic tool for delivering active molecules	24
Potential nanotechnology-based diagnostic and therapeutic approaches for Meniere's disease	23
Intrinsic variability of fluorescence calibrators impacts the assignment of MESF or ERF values to nanoparticles and extracellular vesicles by flow cytometry	23